JP5313659B2 - 皮膚治療組成物 - Google Patents

皮膚治療組成物 Download PDF

Info

Publication number
JP5313659B2
JP5313659B2 JP2008503984A JP2008503984A JP5313659B2 JP 5313659 B2 JP5313659 B2 JP 5313659B2 JP 2008503984 A JP2008503984 A JP 2008503984A JP 2008503984 A JP2008503984 A JP 2008503984A JP 5313659 B2 JP5313659 B2 JP 5313659B2
Authority
JP
Japan
Prior art keywords
composition
luteus
skin
streptococcus
micrococcus luteus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2008503984A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008537549A (ja
Inventor
ロバート タッグ，ジョン
ノーマン チルコット，クリストファー
アブドゥッラ アリ アルカムバー，モハメド
Original Assignee
ブリス テクノロジーズ リミティド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ブリス テクノロジーズ リミティド filed Critical ブリス テクノロジーズ リミティド
Publication of JP2008537549A publication Critical patent/JP2008537549A/ja
Application granted granted Critical
Publication of JP5313659B2 publication Critical patent/JP5313659B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/265—Micrococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2008503984A 2005-03-29 2006-03-29 皮膚治療組成物 Active JP5313659B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ539076 2005-03-29
NZ539076A NZ539076A (en) 2005-03-29 2005-03-29 Skin treatment compositions
PCT/NZ2006/000060 WO2006104403A1 (en) 2005-03-29 2006-03-29 Skin treatment compositions

Publications (2)

Publication Number Publication Date
JP2008537549A JP2008537549A (ja) 2008-09-18
JP5313659B2 true JP5313659B2 (ja) 2013-10-09

Family

ID=37053612

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008503984A Active JP5313659B2 (ja) 2005-03-29 2006-03-29 皮膚治療組成物

Country Status (11)

Country Link
US (1) US8283136B2 (de)
EP (1) EP1863899B1 (de)
JP (1) JP5313659B2 (de)
CN (1) CN101163788B (de)
AU (1) AU2006229563B2 (de)
CA (1) CA2602108C (de)
DK (1) DK1863899T3 (de)
ES (1) ES2430377T3 (de)
NZ (1) NZ539076A (de)
PL (1) PL1863899T3 (de)
WO (1) WO2006104403A1 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019168327A1 (ko) * 2018-02-28 2019-09-06 주식회사 엠디헬스케어 마이크로코커스 속 세균 유래 나노소포 및 이의 용도
US10888591B2 (en) 2018-02-28 2021-01-12 Md Healthcare Inc. Nano-vesicles derived from genus Micrococcus bacteria and use thereof

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3360560A1 (de) * 2012-03-17 2018-08-15 The Regents of the University of California Personalisierte behandlungen für akne
US9913800B2 (en) 2015-04-28 2018-03-13 The Procter & Gamble Company Compositions and methods for improving skin health
AR106611A1 (es) * 2015-11-05 2018-01-31 Natura Cosmeticos Sa Desodorantes y antitranspirantes tópicos de mucina
US10874700B2 (en) 2016-03-31 2020-12-29 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
US10806769B2 (en) 2016-03-31 2020-10-20 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
US9889165B2 (en) 2016-04-21 2018-02-13 Naked Biome, Inc. Compositions and methods for treatment of skin disorders
BE1024425B9 (nl) * 2016-06-21 2018-03-26 Yun NV Dermatologische preparaten voor het onderhouden en/of herstellen van een gezonde huidmicrobiota
WO2018073278A1 (en) * 2016-10-18 2018-04-26 Universite Paris Descartes Cosmetic composition for preventing and/or treating body odor
JP2020500860A (ja) 2016-11-23 2020-01-16 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティック／プレバイオティックな有効成分を含む消毒薬組成物
EP3664819A1 (de) * 2017-08-08 2020-06-17 Université de Versailles Saint Quentin en Yvelines Pharmazeutische zusammensetzung und verfahren zur prävention von staphylococcus aureus mit künstlicher bakterieller kolonisation
CN110680836B (zh) * 2018-06-19 2021-04-02 景岳生物科技(中国)有限公司 副干酪乳杆菌菌株gmnl-653用于制备改善狐臭组合物的用途
EP3666341B1 (de) 2018-12-14 2022-03-23 DWI - Leibniz-Institut für Interaktive Materialien e.V. Topische formulierung in form eines pflasters, verband oder pflaster mit probiotischen bakterien und verwendung davon in einem verfahren zur behandlung oder vorbeugung von hauterkrankungen
US20220184153A1 (en) * 2019-03-25 2022-06-16 The State of Israel, Ministry of Agriculture&Rural Development, Agricltural Research Oganization(ARO Method of treating bovine mastitis
FR3097560B1 (fr) * 2019-06-24 2021-06-25 Oreal Méthode de diagnostic d’une exposition chronique à la pollution
KR102273233B1 (ko) * 2020-05-08 2021-07-06 코스맥스 주식회사 마이크로코커스 루테우스 균주 및 그의 피부 상태 개선 용도
AU2022230052A1 (en) * 2021-03-04 2023-08-24 Blis Technologies Limited Topical composition and use thereof
TW202408552A (zh) * 2022-05-16 2024-03-01 日商瑪路弘股份有限公司 白癬治療用組成物
WO2024047589A1 (en) * 2022-09-02 2024-03-07 Blis Technologies Limited Topical compositions of micrococcus luteus q24 and use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4719109A (en) * 1987-03-27 1988-01-12 E. R. Squibb & Sons, Inc. EM5596--an antibiotic
DE4231544C1 (de) * 1992-09-21 1994-02-03 Richter Chem Lab Kosmetische Mittel
DE4231543C2 (de) * 1992-09-21 1995-06-29 Richter Chem Lab Arzneimittel mit entzündungshemmender Wirkung
WO1995030751A1 (en) * 1994-05-07 1995-11-16 Ciba-Geigy Ag Lanthionine-containing antimicrobial compound
NL1000681C2 (nl) * 1995-06-28 1996-12-31 Suiker Unie Deo-samenstelling.
ATE215378T1 (de) * 1996-06-20 2002-04-15 Novartis Ag Micrococcin antibiotika zur prävention und therapie der mastitis
KR100211674B1 (ko) * 1997-02-25 1999-08-02 윤종용 과산화수소에 저항성을 갖는 신규 미생물
DE10027928A1 (de) * 2000-06-06 2002-01-03 Peter Michael Siemens Verwendung von Fettsäureoligoethylenglykolester-Derivaten zur Behandlung von bakteriellen Infektionen sowie zum Einsatz als Bakterizid, Konservierungs-und Desinfektionsmittel.
DE20214753U1 (de) * 2002-09-24 2002-12-12 Hando Handels Ges. M.B.H., Graz Pharmazeutische Zusammensetzung zur Behandlung und/oder Prävention einer Lichtdermatose
US20080193393A1 (en) * 2004-09-24 2008-08-14 Lipo Chemicals Inc. Delivery System for Topically Applied Compounds
KR20080064139A (ko) * 2005-11-01 2008-07-08 다우 코닝 코포레이션 활성제를 함유하는 실리콘 소포체

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019168327A1 (ko) * 2018-02-28 2019-09-06 주식회사 엠디헬스케어 마이크로코커스 속 세균 유래 나노소포 및 이의 용도
US10888591B2 (en) 2018-02-28 2021-01-12 Md Healthcare Inc. Nano-vesicles derived from genus Micrococcus bacteria and use thereof

Also Published As

Publication number Publication date
ES2430377T3 (es) 2013-11-20
CN101163788B (zh) 2011-09-14
CA2602108C (en) 2018-08-14
US20110189133A1 (en) 2011-08-04
CA2602108A1 (en) 2006-10-05
US8283136B2 (en) 2012-10-09
DK1863899T3 (da) 2013-10-14
CN101163788A (zh) 2008-04-16
EP1863899A4 (de) 2009-12-30
AU2006229563B2 (en) 2012-01-12
EP1863899A1 (de) 2007-12-12
WO2006104403A1 (en) 2006-10-05
JP2008537549A (ja) 2008-09-18
NZ539076A (en) 2008-05-30
EP1863899B1 (de) 2013-07-10
PL1863899T3 (pl) 2014-01-31
AU2006229563A1 (en) 2006-10-05

Similar Documents

Publication Publication Date Title
JP5313659B2 (ja) 皮膚治療組成物
KR100797819B1 (ko) 피부의 병원균총에 대해 항부착성인 물질
US7618658B2 (en) Anti-microbial agent and anti-microbial composition
US20210361978A1 (en) Dermatological preparations for maintaining and/or restoring healthy skin microbiota
EP1212093B1 (de) Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien
AU783418B2 (en) Improved topical compositions containing probiotic bacteria, spores, and extracellular products and uses thereof
KR20140032413A (ko) 신규 락트산 박테리아 및 그를 함유하는 조성물
CN109890955A (zh) 耐受抗菌剂的乳酸菌
EP3774855B1 (de) Eine antimikrobielle zusammensetzung zur selektiven wachstumshemmung von p. acnes bakterien
WO2023282356A1 (ja) 口腔用組成物、および口腔内疾患の予防または治療方法
EP3883596A1 (de) Antimikrobielle zusammensetzung zur selektiven hemmung des wachstums von p.-acnes-bakterien
AU2006201179B2 (en) Use of Emu Oil Carrier for Antifungal, Antibacterial, and Antiviral Medications
KR102486025B1 (ko) 생유산균을 포함하고 질염 개선에 도움을 주는 여성청결제용 조성물
KR20180059296A (ko) 가자 추출물 및 애엽 추출물을 함유하는 피부세균총의 생장 조절 또는 피부 면역 강화용 조성물
CN118139633A (zh) 用于抑制真菌增殖的益生菌组合物
WO2010032043A2 (en) Formulations

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090311

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20110809

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110823

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20111124

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20111201

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120223

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120619

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120904

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130604

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130704

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 5313659

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250